Floatz logo

Givinostat

Polycytemia Vera

ItalfarmacoSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Polycytemia Vera cohort.

Asset / SponsorPhaseRating
Ruxolitinib
University of Washington
Phase 4BB
TACROLIMUS
Thomas Jefferson University
Phase 2BB
Pegylated-Proline-Interferon Alpha-2B
AOP Orphan Pharmaceuticals AG
Phase 3BB
Fludarabine
Thomas Jefferson University
Phase 2BB
Cyclophosphamide
Thomas Jefferson University
Phase 2BB

View all 36 →

Same molecule, other indications

Givinostat is also rated in:

Duchenne muscular dystrophyDormant
BB
Indicative ·
64 / 100
View asset →
Becker muscular dystrophyDormant
CCC
Indicative ·
54 / 100
View asset →
Hodgkins lymphomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →